Lexeo Therapeutics

heart beat cardiogram pulse cardio

Biotech

Lexeo links gene therapy to improvements in rare heart disease

Lexeo Therapeutics ran into problems when testing the effect of a Friedreich ataxia gene therapy on fitness and was left with a gap in its evidence.

Nick Paul Taylor Jul 15, 2024 9:46am

parachute snow mountains

Takeda welcomes new oncology chief from CRISPR—Chutes & Ladders

Feb 9, 2024 9:30am

IPO initial public offering Wall Street

Lexeo drops share price at last minute to raise $100M IPO

Nov 3, 2023 8:19am

Wall Street stock exchange new York shares market

Two biotechs go public while Apnimed bides its time

Oct 2, 2023 11:02am

topic report

Fierce Biotech's 2022 Fierce 15

Sep 12, 2022 3:00am

Gene therapy

Lexeo keeps foot on the gas pedal with $100M financing

Sep 9, 2021 6:00am